These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 18295734

  • 1. Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?
    Behrens EM.
    Autoimmun Rev; 2008 Feb; 7(4):305-8. PubMed ID: 18295734
    [Abstract] [Full Text] [Related]

  • 2. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases.
    Tristano AG.
    Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366
    [Abstract] [Full Text] [Related]

  • 3. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis.
    Hazen MM, Woodward AL, Hofmann I, Degar BA, Grom A, Filipovich AH, Binstadt BA.
    Arthritis Rheum; 2008 Feb; 58(2):567-70. PubMed ID: 18240215
    [Abstract] [Full Text] [Related]

  • 4. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
    Behrens EM, Beukelman T, Paessler M, Cron RQ.
    J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
    [Abstract] [Full Text] [Related]

  • 5. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
    Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G.
    J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis A-associated macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: report of 2 cases.
    Russo RA, Rosenzweig SD, Katsicas MM.
    J Rheumatol; 2008 Jan; 35(1):166-8. PubMed ID: 18050365
    [Abstract] [Full Text] [Related]

  • 7. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.
    Avcin T, Tse SM, Schneider R, Ngan B, Silverman ED.
    J Pediatr; 2006 May; 148(5):683-6. PubMed ID: 16737887
    [Abstract] [Full Text] [Related]

  • 8. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age.
    Stabile A, Bertoni B, Ansuini V, La Torraca I, Sallì A, Rigante D.
    Eur Rev Med Pharmacol Sci; 2006 May; 10(2):53-9. PubMed ID: 16705949
    [Abstract] [Full Text] [Related]

  • 9. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
    Castillo L, Carcillo J.
    Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
    [Abstract] [Full Text] [Related]

  • 10. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
    Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, Martini A, Ravelli A.
    Lupus; 2007 May; 16(8):587-92. PubMed ID: 17711893
    [Abstract] [Full Text] [Related]

  • 11. Macrophage activation syndrome in juvenile idiopathic arthritis.
    Cortis E, Insalaco A.
    Acta Paediatr Suppl; 2006 Jul; 95(452):38-41. PubMed ID: 16801165
    [Abstract] [Full Text] [Related]

  • 12. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.
    Ramanan AV, Rosenblum ND, Feldman BM, Laxer RM, Schneider R.
    J Rheumatol; 2004 Oct; 31(10):2068-70. PubMed ID: 15468377
    [Abstract] [Full Text] [Related]

  • 13. Recognition and management of macrophage activation syndrome in juvenile arthritis.
    Kelly A, Ramanan AV.
    Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614
    [Abstract] [Full Text] [Related]

  • 14. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, Bader-Meunier B, Westhovens R, Van den Eynde BJ, Orabona C, Fallarino F, De Somer L, Tousseyn T, Quartier P, Wouters C, Matthys P.
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [Abstract] [Full Text] [Related]

  • 15. Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan.
    Chen HH, Kuo HC, Wang L, Yu HR, Shen JM, Kwang KP, Yang KD.
    J Microbiol Immunol Infect; 2007 Jun; 40(3):265-71. PubMed ID: 17639169
    [Abstract] [Full Text] [Related]

  • 16. Etanercept for therapy-resistant macrophage activation syndrome.
    Makay B, Yilmaz S, Türkyilmaz Z, Unal N, Oren H, Unsal E.
    Pediatr Blood Cancer; 2008 Feb; 50(2):419-21. PubMed ID: 16900487
    [Abstract] [Full Text] [Related]

  • 17. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
    Ramanan AV, Schneider R.
    J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
    [Abstract] [Full Text] [Related]

  • 18. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
    Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, Toma T, Ohta K, Kasahara Y, Yachie A.
    Rheumatology (Oxford); 2010 Sep; 49(9):1645-53. PubMed ID: 20472718
    [Abstract] [Full Text] [Related]

  • 19. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?
    Ramanan AV, Grom AA.
    Rheumatology (Oxford); 2005 Nov; 44(11):1350-3. PubMed ID: 15956091
    [Abstract] [Full Text] [Related]

  • 20. The History of Macrophage Activation Syndrome in Autoimmune Diseases.
    Silverman ED.
    Adv Exp Med Biol; 2024 Nov; 1448():21-31. PubMed ID: 39117805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.